Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 1523124, 7 pages
http://dx.doi.org/10.1155/2016/1523124
Research Article

Association between the Achievement of Target Range CKD-MBD Markers and Mortality in Prevalent Hemodialysis Patients in Taiwan by Using the Kidney Disease: Improving Global Outcomes Clinical Guidelines

1Department of Nephrology, Tianjin First Center Hospital, Tianjin, China
2Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan

Received 28 August 2016; Revised 18 October 2016; Accepted 6 November 2016

Academic Editor: Kazim Husain

Copyright © 2016 Ying Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD),” Kidney International Supplement, no. 113, pp. S1–S130, 2009.
  2. G. A. Block, T. E. Hulbert-Shearon, N. W. Levin, and F. K. Port, “Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study,” The American Journal of Kidney Diseases, vol. 31, no. 4, pp. 607–617, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Tentori, M. J. Blayney, J. M. Albert et al., “Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS),” The American Journal of Kidney Diseases, vol. 52, no. 3, pp. 519–530, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. G. A. Block, P. S. Klassen, J. M. Lazarus, N. Ofsthun, E. G. Lowrie, and G. M. Chertow, “Mineral metabolism, mortality, and morbidity in maintenance hemodialysis,” Journal of the American Society of Nephrology, vol. 15, no. 8, pp. 2208–2218, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. L. A. Stevens, O. Djurdjev, S. Cardew, E. C. Cameron, and A. Levin, “Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes,” Journal of the American Society of Nephrology, vol. 15, no. 3, pp. 770–779, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Slinin, R. N. Foley, and A. J. Collins, “Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study,” Journal of the American Society of Nephrology, vol. 16, no. 6, pp. 1788–1793, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Kalantar-Zadeh, N. Kuwae, D. L. Regidor et al., “Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients,” Kidney International, vol. 70, no. 4, pp. 771–780, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. “K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease,” The American Journal of Kidney Diseases, vol. 42, no. 4, supplement 3, pp. S1–S201, 2003.
  9. E. W. Young, T. Akiba, J. M. Albert et al., “Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS),” The American Journal of Kidney Diseases, vol. 44, no. 5, supplement 2, pp. 34–38, 2004. View at Google Scholar
  10. M. Wei, H. Taskapan, K. Esbaei, S. V. Jassal, J. M. Bargman, and D. G. Oreopoulos, “K/DOQI guideline requirements for calcium, phosphate, calcium phosphate product, and parathyroid hormone control in dialysis patients: can we achieve them?” International Urology and Nephrology, vol. 38, no. 3-4, pp. 739–743, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Cozzolino, P. Messa, D. Brancaccio et al., “Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients: results of the FARO-2 cohort,” Blood Purification, vol. 38, no. 1, pp. 37–45, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Tangri, M. Wagner, J. L. Griffith et al., “Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom renal registry,” The American Journal of Kidney Diseases, vol. 57, no. 3, pp. 415–421, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Fouque, H. Roth, S. Pelletier et al., “Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets?” Nephrology Dialysis Transplantation, vol. 28, no. 2, pp. 360–367, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Kong, L. Zhang, L. Zhang et al., “Mineral and bone disorder in Chinese dialysis patients: a multicenter study,” BMC Nephrology, vol. 13, article 116, 2012. View at Publisher · View at Google Scholar
  15. J. T. Daugirdas, “The post: pre-dialysis plasma urea nitrogen ratio to estimate K.t/V and NPCR: mathematical modeling,” The International Journal of Artificial Organs, vol. 12, no. 7, pp. 411–419, 1989. View at Google Scholar · View at Scopus
  16. M. Taniguchi, M. Fukagawa, N. Fujii et al., “Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients,” Therapeutic Apheresis and Dialysis, vol. 17, no. 2, pp. 221–228, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Wald, M. J. Sarnak, H. Tighiouart et al., “Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study,” The American Journal of Kidney Diseases, vol. 52, no. 3, pp. 531–540, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Floege, J. Kim, E. Ireland et al., “Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population,” Nephrology Dialysis Transplantation, vol. 26, no. 6, pp. 1948–1955, 2011. View at Publisher · View at Google Scholar · View at Scopus